AFJK Aimei Health Technology Co., Ltd
XNASStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
What changed
Recent filings, trades and moves- Nov 17 Reports earnings
- Nov 5 8-K: New debt obligation
- Industry (SIC)
- BLANK CHECKS (6770)
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 2
- List Date
- 2024-01-22
- CIK
- 0001979005
- Next Earnings
- 2026-11-17
- Headquarters
- New York, NY
Aimei Health Technology Co Ltd is a blank check company.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '24 | '25 | '26 | Avg |
|---|---|---|---|---|
| Jan | 0.30% | 0.19% | -30.66% | -10.06% |
| Feb | -0.16% | 1.86% | -39.89% | -12.73% |
| Mar | 0.84% | 0.34% | -26.51% | -8.44% |
| Apr | 0.00% | 0.45% | 71.91% | 24.12% |
| May | 0.44% | 1.41% | -9.05% | -2.40% |
| Jun | 0.29% | 0.00% | -24.25% | -7.99% |
| Jul | 0.38% | 1.80% | -57.00% | -18.27% |
| Aug | 0.39% | 1.16% | -0.95% | 0.20% |
| Sep | 0.29% | 0.35% | 0.83% | 0.49% |
| Oct | 0.86% | 0.88% | -3.10% | -0.45% |
| Nov | 0.28% | -5.78% | 1.64%* | -1.29% |
| Dec | 0.94% | 601.86% | -- | 301.40% |
| Total | 4.95% | 619.13% | -84.66% | 179.81% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report: AFJK
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Technical indicators suggest a neutral market with a bearish momentum signal
- Recent news headlines are mixed, with no clear sentiment bias
- Risk metrics indicate a relatively low-volatility stock with a negative beta
Primary Risks:
- Bearish momentum signal from MACD and Stochastic Oscillators
- Overbought conditions in the short-term (RSI above 70)
- Lack of earnings data for risk assessment and investment thesis development
Recent News Sentiment Impact: NEUTRAL
Technical Analysis
Trend Direction: Short-term - BEARISH, Medium-term - NEUTRAL, Long-term - BULLISH
Support/Resistance Levels:
- Key support level at $34.02 (current price)
- Resistance levels at $38.97 (SMA 20) and $41.86 (SMA 50)
Momentum Signals:
- RSI: 41.33 (neutral, not overbought or oversold)
- MACD: Bearish momentum signal with a histogram value of -1.40
- Stochastic Oscillators: Neutral to bearish signals
Volume Analysis: Volume trends and institutional interest signals are mixed.
News & Sentiment Analysis
Recent Headlines Summary:
- One neutral news headline about United Hydrogen Group Inc.'s business combination agreement with Aimei Health Technology Co., Ltd.
Sentiment Assessment: NEUTRAL (Aggregate sentiment from recent headlines)
Catalyst Identification: No earnings data available, but potential catalysts could be product launches or regulatory changes
Market Narrative: Technical signals are mixed, with no clear bias in the short-term. The market is waiting for a catalyst to trigger a significant move.
Risk & Volatility Assessment
Risk Metrics:
- Beta: -0.22 (vs SPY), indicating a relatively low-risk stock
- Alpha: 15.64, suggesting strong performance relative to the S&P 500
- Correlation: -0.00, indicating no correlation with the market
Options Market Signals:
- IV Premium vs HV30 is N/A (no data available)
Downside Protection: Support levels at $34.02 and potential buy signals from RSI and Stochastic Oscillators.
Market Context & Positioning
Sector Performance: AFJK is outperforming its sector by 2.56% in the short-term.
Institutional Activity: No clear institutional interest or volume patterns suggesting buying or selling pressure.
Correlation Analysis: AFJK has a negative correlation with the market, indicating it tends to move opposite the market direction.
Relative Valuation: The stock is trading within a neutral range relative to its sector and industry peers.
Key Levels & Action Items
Critical Price Levels:
- Support level at $34.02
- Resistance levels at $38.97 (SMA 20) and $41.86 (SMA 50)
Breakout/Breakdown Levels: No clear technical signals for a breakout or breakdown.
Time-Sensitive Catalysts: No earnings data available, but potential product launches or regulatory changes could be catalysts.
Risk Management: Consider setting stop-loss levels at $32.50 to mitigate potential losses in case of a bearish move.
Please note that this analysis is based on the provided data and should not be taken as investment advice.
AFJK Options Activity & IV Rank
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Loading the implied volatility surface…
Loading the implied volatility smile…
Risk Metrics
Analysis Details
Data Points: 232
Period: 252 trading days
Low volatility - stock moves less than market
AFJK Institutional Ownership (13F)
Filings for 2026-06-30 · 2 already for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
AFJK Board & Officers
As of SEC filings through Jul 1, 2026Directors 1
- Daniel Veikko Polvi · since Jun 29, 2026
Changes in the last 10 years (13)
| Jun 29, 2026 | Daniel Veikko Polvi became a director |
| Feb 11, 2025 | Mizuho Securities USA LLC reported in an SEC filing no longer being a 10% owner |
| Feb 10, 2025 | Mizuho Securities USA LLC became a 10% owner |
| Apr 15, 2024 | The company announced the departure of Juan Fernandez Pascual from the board in an SEC filing |
| Apr 15, 2024 | The company announced the departure of Juan Fernandez Pascual as CEO and Secretary in an SEC filing |
| Nov 30, 2023 | Robin H. Karlsen became a director |
| Nov 30, 2023 | Lin Bao became a director |
| Nov 30, 2023 | Julianne Huh became a director |
| Nov 30, 2023 | Juan Fernandez Pascual became a director |
| Nov 30, 2023 | Juan Fernandez Pascual became CEO and Secretary |
| Nov 30, 2023 | Heung Ming Henry Wong became a director |
| Nov 30, 2023 | Heung Ming Henry Wong became Chief Financial Officer |
| Nov 30, 2023 | Aimei Investment Ltd became a 10% owner |
Not reported recently (5)
- Aimei Investment Ltd · Last reported as a 10% owner in an SEC filing dated Dec 5, 2023
- Lin Bao · Last reported as a director in an SEC filing dated Nov 30, 2023
- Julianne Huh · Last reported as a director in an SEC filing dated Nov 30, 2023
- Robin H. Karlsen · Last reported as a director in an SEC filing dated Nov 30, 2023
- Heung Ming Henry Wong · Last reported as a director in an SEC filing dated Nov 30, 2023
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-05 | New debt obligation | EDGAR |
| 2026-10-05 | New debt obligation | EDGAR |
| 2026-09-03 | New debt obligation | EDGAR |
| 2026-08-25 | Listing standards notice | EDGAR |
| 2026-08-06 | New debt obligation | EDGAR |
| 2026-07-08 | Agreement terminated · Regulation FD disclosure | EDGAR |
| 2026-07-06 | New debt obligation | EDGAR |
| 2026-06-29 | Director or officer change | EDGAR |
| 2026-06-04 | New debt obligation | EDGAR |
| Filing Date | Accession | Link |
|---|
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
AFJK vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| CCCX Churchill Capital Corp X Class A Ordinar | $711M | — | — | −19.1% | — |
| DMII Drugs Made In America Acquisition II Cor | $652M | — | — | +3.3% | — |
| EVAC EQV Ventures Acquisition Corp. II | $606M | — | — | +3.4% | — |
| BCSS Bain Capital GSS Investment Corp. | $597M | — | — | +1.2% | — |
| CEPF Cantor Equity Partners IV, Inc. Class A | $591M | — | — | −0.1% | — |
| CXII Churchill Capital Corp XII Class A Ordin | $576M | — | — | +3.9% | — |
| CAEP Cantor Equity Partners III, Inc. Class A | $526M | — | — | +46.9% | — |
| AEXA American Exceptionalism Acquisition Corp | $524M | — | — | −7.2% | 45 |
| AFJK Aimei Health Technology Co., Ltd Ordinar | $38M | — | — | −83.7% | — |
| Peer median | $594M | — | — | +2.3% | 45 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.